Is Aehr Test Systems (AEHR) a risky stock?
As of July 27, 2026, Clavix grades Aehr Test Systems (AEHR) F for risk, a composite score of 30 out of 100 on an A+ to F scale, which puts AEHR in the "distressed" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 27, 2026. Clavix regrades every trading day.
AEHR price, last 3 months
AEHR's daily closes over the past three months. Clavix reads risk from the fundamentals and news behind the price, not the line itself.
The five risk dimensions behind AEHR's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how AEHR scores on each, as of July 27, 2026.
What's moving AEHR's risk right now
Company-specific signals Clavix flags behind AEHR's current grade, drawn from recent news and filings as of July 27, 2026.
Shares of Aehr Test Systems rose 15.4% last week, with data framing the company as a proxy for AI semiconductor spending. An SEC 8-K material event filing also appeared on July 24, 2026.
Aehr Test jumped 27.9% on expectations of roughly 3x revenue growth, with data citing strong AI-related demand and a solid backlog pointing to a big revenue jump in fiscal 2027.
Aehr Test shares opened at $83.25 after closing at $77.36 the prior session, later trading around $92.35. The gap up reflects a sharp one-day move higher with no specific catalyst cited in the data.
Recent AEHR news
The latest headlines Clavix ingested for Aehr Test Systems, newest first. These feed the news-sentiment dimension of AEHR's grade.
What a F grade means
On the Clavix A+ to F scale, AEHR's composite of 30 falls in the F band (0–34), read as "distressed." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell AEHR or any security. Grades are risk indicators, not predictions of return. Data may be delayed.